NEW YORK (Reuters) - Biotech company Amgen Inc is scheduled to plead guilty on Tuesday in a criminal case in federal court in Brooklyn, New York, prosecutors said.
A brief statement from the U.S. Attorney's office gave no details of the charges Amgen would plead guilty to.
Representatives of Amgen could not immediately be reached to comment.
(Reporting by Jessica Dye)
(c) Copyright Thomson Reuters 2012. Check for restrictions at: http://about.reuters.com/fulllegal.asp